Anzeige
❌
Mehr »
Freitag, 09.10.2026 - Börsentäglich über 12.000 News
Elevate Sercive Group: Neue Expertise für den nächsten Wachstumsschritt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
OL

WKN: A3D493 | ISIN: US68163W2089 | Ticker-Symbol: OLY
Siehe auch OLYMPUS CORPORATION
Frankfurt
09.10.26 | 09:55
10,700 Euro
0,00 % 0,000
Branche
Gesundheitswesen
Aktienmarkt
JAPAN
1-Jahres-Chart
OLYMPUS CORPORATION ADR Chart 1 Jahr
5-Tage-Chart
OLYMPUS CORPORATION ADR 5-Tage-Chart

Aktuelle News zur OLYMPUS CORPORATION ADR Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
31.08.Olympus launches Powerseal open extended jaw device11
14.08.Olympus to globally distribute Endocision's respiratory cryocatheter6
13.08.Olympus Announces Global Distribution Agreement with Endocision for Respiratory Cryobiopsy System604Portable Device is Designed to Support a Variety of Clinical NeedsWESTBOROUGH, Mass., Aug. 13, 2026 /PRNewswire/ -- Olympus Corporation (Olympus), a global MedTech company committed to advancing...
► Artikel lesen
07.08.Olympus Q1 FY27 slides: GIS drives 16% revenue growth, margins expand5
07.08.Olympus Aktie legt nach starkem Quartalsergebnis um 1,82 % zu5
07.08.Olympus GAAP EPS of ¥17.72, revenue of ¥240.4B; reaffirms FY 2027 outlook3
OLYMPUS CORPORATION ADR Aktie jetzt für 0€ handeln
07.08.Olympus Corporation Reports Advance In Q1 Bottom Line469TOKYO (dpa-AFX) - Olympus Corporation (OCPNF) reported earnings for its first quarter that Increased, from last yearThe company's earnings totaled JPY19.102 billion, or JPY17.72 per share. This...
► Artikel lesen
27.05.Olympus: $270 Million BioProtect Acquisition Expands Urology And Prostate Cancer Portfolio3
26.05.Japan's Olympus buys Israeli co BioProtect for $270m7
26.05.Olympus to acquire urologic balloon spacer maker BioProtect for $270M16
26.05.Olympus to buy Israel's BioProtect for $270 million in cash7
26.05.OLYMPUS CORPORATION: FINANCIAL STATEMENTS AND RELATED ANNOUNCEMENT::FULL YEARLY RESULTS3
12.05.Olympus reports FY results4
12.05.Olympus FY2026 slides: FDA impact absorbed, margin expansion targeted18
12.05.Olympus Full-Year Profit Falls Despite Higher Revenue; Sees Growth In 2027 675TOKYO (dpa-AFX) - Olympus Corporation (OCPNF), a manufacturer of optics and reprography products, on Tuesday reported profit before tax of 93.994 billion yen for the fiscal year ended March...
► Artikel lesen
04.05.Olympus inks distro deal with EndoRobotics to boost EndoTherapy portfolio with robot-assisted tech1
28.04.Olympus wins FDA clearance for Powerseal open extended jaw device2
13.02.Olympus Corporation Nine Months Income Drops695TOKYO (dpa-AFX) - Olympus Corporation (OCPNF) released a profit for nine months that Dropped, from the same period last yearThe company's earnings totaled JPY43.357 billion, or JPY38.80 per...
► Artikel lesen
03.02.Olympus Corporation: EAGLE Trial Shows Olympus(R) CADDIE AI Solution Aids in the Detection of High-Risk and Hard-to-Detect Colorectal Lesions1.278Cloud-based AI application for colorectal cancer prevention: Enhancing detection of clinically significant lesions without compromising safety and workflow efficiencyTOKYO, Feb 3, 2026 - (JCN Newswire)...
► Artikel lesen
15.12.25Olympus Corporation: Olympus Triples Venture Capital Fund Investment to Strengthen MedTech Leadership1.834Second fund of $150 million targets MedTech innovation - advancing devices, digital solutions, and diagnosticsTOKYO and WESTBOROUGH, Mass., Dec 15, 2025 - (JCN Newswire) - Olympus Corporation (Olympus)...
► Artikel lesen
1 2 Weiter >>
26 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1